EVOLVING AZIMUTH IN MUSA CONTEXT

Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Jun 11, 2025

Keywords

ClinConnect Summary

The clinical trial titled "EVOLVING AZIMUTH IN MUSA CONTEXT" is investigating how using telemedicine, particularly a telemonitoring service, can help patients with heart failure. The study aims to understand both the benefits and challenges that come from this approach. By participating, you may help researchers learn how telemonitoring can improve health management and patient care for those dealing with heart failure.

To be eligible for this trial, you need to be at least 18 years old and have been diagnosed with chronic heart failure. You should also have access to a smartphone that can run the required app and have a stable internet connection at home. Participants will be asked to use the telemonitoring service and share their experiences, which will help shape future healthcare solutions. If you have a severe psychiatric disorder or struggle to use technology, this study may not be suitable for you. Overall, your involvement could contribute to better understanding and support for heart failure patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have been diagnosed with chronic CS according to the ESC guidelines;
• • Over 18 years of age;
• • Patients admitted to hospital or with access to first aid within the last year;
• • Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
• • Wi-Fi or 3G coverage at home;
• • Ability to give written informed consent.
• Exclusion Criteria:
• • Severe psychiatric disorder
• • Inability to use portable technologies
• • Patients unable to use the equipment provided
• • Patients who deny consent to study participation